Trials / Completed
CompletedNCT03870971
User Evaluation of the Invasive Component of the CNOGA TensorTip COMBO GLUCOMETER (CoG)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 543 (actual)
- Sponsor
- Sciema UG · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Open label, prospective, comparative, multi-center study. All participants will get an introduction to the invasive component of the TENSORTIP COG by means of the instructions for use in English language only (incl. an illustrated short manual) and will be asked to perform a reading without further device training. Thereafter, a healthcare professional will perform an additional reading with the reference method (YSI 2300 STAT plus). In addition, blood will be drawn for determination of hematocrit. In the study, a minimum of 10 test strip vials that cover a minimum of 3 strip lots will be used. In addition multiple devices will be employed. After completion of the study the study participants will be given a questionnaire to fill out.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood glucose measurement | After the patient has performed the manual reading, the investigator or staff member will obtain another capillary blood sample and a reference reading by means of the YSI 2300 Stat plus analyzer will be performed and recorded. If patients need more than one attempt to get a successful blood glucose reading, the number of attempts will be documented. A questionnaire needs to filled by the participant |
Timeline
- Start date
- 2019-02-04
- Primary completion
- 2019-07-08
- Completion
- 2019-08-31
- First posted
- 2019-03-12
- Last updated
- 2020-01-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03870971. Inclusion in this directory is not an endorsement.